Pricing Log in Create free account

SAB Biotherapeutics, Inc. (SABS) vs Vogenx Inc (VOGX)

SAB Biotherapeutics, Inc. and Vogenx Inc are both Biotechnology companies. SAB Biotherapeutics, Inc. and Vogenx Inc are of similar size ($270.8M and $267.5M). Across the 4 metrics below, Vogenx Inc leads on 3 and SAB Biotherapeutics, Inc. on 1.

Valuation

Metric SABS VOGX Biotechnology median
P/E n/m — 10.60
P/S 147.02 n/m 9.40
P/B 1.11 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 85.82 n/m 9.02
Earnings yield (6.31%) — (32.88%)
Free cash flow yield (24.01%) 0.00% (23.13%)

Profitability

Metric SABS VOGX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (34.27%) — (51.96%)
Return on assets (28.97%) — (46.06%)
Return on invested capital (38.97%) 0.00% 0.00%

Growth

Metric SABS VOGX Biotechnology median
Revenue growth (TTM) (60.26%) — 6.76%
EPS growth (last fiscal year) 78.53% — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR (26.69%) — 0.00%

Health

Metric SABS VOGX Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 9.22 0.44 4.97
Net debt to EBITDA 2.03 — 1.01

Dividend

Metric SABS VOGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SABS VOGX Biotechnology median
Market cap 267.50m 270.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack